???global.info.a_carregar???
Rita Azevedo graduated in Biochemistry from the Instituto Universitário de Ciências of CESPU group in 2012. She started her research pathway in the field of pharmacogenetics by integrating the Molecular Oncology Group & Viral Pathology – Research Centre, Portuguese Institute of Oncology – Porto, for two years. Rita Azevedo completed an MSc in Medical Informatics in 2014 from the Faculty of Medicine of the University of Porto, with a dissertation about mobile health (mHealth) for disease self-management. In 2014 she started her PhD degree in Pathology and Molecular Genetics at the Abel Salazar Biomedical Sciences Institute of the University of Porto aimed to develop novel therapeutic strategies based on glycoproteins in bladder cancer, with funding from a grant from the Foundation for the Science and Technology (FCT) (SFRH/BD/105355/2014). She also joined the Experimental Pathology and Therapeutics Group of the Portuguese Institute of Oncology – Porto, the host institution where the PhD work has been developed. Her thesis has set a roadmap for glycobiomarker discovery in bladder cancer (cell lines, biopsies, and urine samples), exploring the full potential of glycomics, glycoproteomics, and high-resolution mass spectrometry. Moreover, it has set the foundations for glycoepitopes synthesis and purification, providing the necessary structural and clinical rationale for supporting the development of novel glycan-based theranostics applications. In 2020, Rita Azevedo had her first abroad experience and started as a post-doctoral researcher in the Pulliainen-laboratory at the University of Turku, Finland. She was interested in conducting proteomics in Salmonellosis models and exploring ADP-ribosylation using high-resolution mass spectrometry (DDA). In 2021, she moved to France and started as a research engineer in the François Becher group at CEA Saclay, Ille-de-France. She characterized and quantified tau protein in Alzheimer’s disease using high-resolution mass spectrometry (DDA and PRM), aiming to find novel tau proteoforms as biomarkers. At two months before the end of 2022, she joined as a research engineer to Matondo’s Proteomics Platform UTechS Mass Spectrometry for Biology Utechs (MSBio), Institut Pasteur. Rita Azevedo published 31 scientific articles (11 publications as 1st author, 8 reviews; mean journal impact factor of 4.37) with a cumulative journal impact factor of 135, an H-index of 22 (Scopus), and a total citations number of 1,058 (Scopus, Author ID: 55825758200).
Ler resumo completo ↓
Identificação

Identificação pessoal

Nome completo
Ana Rita Pereira Azevedo

Nomes de citação

  • Azevedo, Rita
  • Pereira Azevedo, Ana Rita

Identificadores de autor

Ciência ID
251F-01FE-9403
ORCID iD
0000-0002-3015-9675

Websites

Domínios de atuação

  • Ciências da Engenharia e Tecnologias - Outras Ciências da Engenharia e Tecnologias
  • Ciências Médicas e da Saúde - Ciências da Saúde

Idiomas

Idioma Conversação Leitura Escrita Compreensão Peer-review
Português (Idioma materno)
Inglês Utilizador proficiente (C2) Utilizador proficiente (C2) Utilizador proficiente (C2) Utilizador proficiente (C2) Utilizador proficiente (C2)
Francês Utilizador elementar (A1) Utilizador elementar (A2) Utilizador elementar (A1) Utilizador elementar (A2) Utilizador elementar (A1)
Espanhol; Castelhano Utilizador elementar (A1) Utilizador elementar (A1) Utilizador elementar (A1) Utilizador elementar (A1) Utilizador elementar (A1)
Formação
Grau Classificação
2015 - 2019
Concluído
 Patologia e Genética Molecular (Doutoramento)
Especialização em Sem especialidade
Universidade do Porto Instituto de Ciências Biomédicas Abel Salazar, Portugal
"Development of monoclonal antibodies for bladder cancer based on glycobiomarkers: identification of relevant glycoantigens and synthesis methodologies thereof" (TESE/DISSERTAÇÃO)
 Aprovado
2012 - 2014
Concluído
 Informática Médica (Mestrado)
Universidade do Porto Faculdade de Medicina, Portugal
"Development of a Smartphone application for Rheumatoid Arthritis self-management" (TESE/DISSERTAÇÃO)
 17 valores (em 20 valores)
2009 - 2012
Concluído
 Bioquímica (Licenciatura)
Instituto Universitário de Ciências da Saúde, Portugal
"Polimorfismos genéticos do Timidilato Sintetase no tratamento da Artrite Reumatoide" (TESE/DISSERTAÇÃO)
 15 valores (em 20 valores)
Percurso profissional

Ciência

Categoria Profissional
Instituição de acolhimento 		Empregador
2024/11/01 - Atual Investigador (Investigação) Instituto Português de Oncologia do Porto Francisco Gentil EPE, Portugal
Instituto Português de Oncologia do Porto Francisco Gentil Centro de Investigação, Portugal
2022/11/02 - 2023/11/30 Investigador Contratado (Investigação) Institut Pasteur, França
Institut Pasteur, França
2021/03/01 - 2022/09/06 Investigador Contratado (Investigação) Commissariat a l'energie atomique et aux energies alternatives Centre de Saclay, França
2020/02/01 - 2021/01/31 Pós-doutorado (Investigação) Turun yliopisto, Finlândia
2015/03 - 2019/06/04 Investigador (Investigação) Instituto Português de Oncologia do Porto Francisco Gentil EPE, Portugal
2013/10 - 2014/12 Estagiário de Investigação (Investigação) Instituto Português de Oncologia do Porto Francisco Gentil EPE, Portugal
2012/02 - 2012/08 Estagiário de Investigação (Investigação) Instituto Português de Oncologia do Porto Francisco Gentil EPE, Portugal
Projetos

Bolsa

Designação Financiadores
2015/03 - 2019/03 Development of monoclonal antibodies for chemoresistant bladder cancer based on glycobiomakers
SFRH/BD/105355/2014
 Fundação para a Ciência e a Tecnologia, I.P.
Produções

Publicações

Artigo em revista
  1. Moona Sakari; Rajendra Bhadane; Sujit Kumar; Rita Azevedo; Morteza Malakoutikhah; Ahmadreza Masoumi; Dene R. Littler; et al. "ADP-ribosyltransferase-based biocatalysis of nonhydrolyzable NAD+ analogs". Journal of Biological Chemistry (2025): https://doi.org/10.1016/j.jbc.2024.108106.
    10.1016/j.jbc.2024.108106
  2. Ferreira E; Ferreira D; Relvas-Santos M; Freitas R; Soares J; Azevedo R; Afonso LP; et al. "Aberrantly Glycosylated GLUT1 as a Poor Prognosis Marker in Aggressive Bladder Cancer.". International journal of molecular sciences (2024): http://europepmc.org/abstract/med/38542435.
    10.3390/ijms25063462
  3. Jacquemin C; Villain N; Azevedo R; Boluda S; Thévenot EA; Fenaille F; Lamari F; Becher F. "Evaluation of SP3 for antibody-free quantification of tau in CSF mimic and brain by mass spectrometry.". European journal of mass spectrometry (Chichester, England) (2024): http://europepmc.org/abstract/med/38258392.
    10.1177/14690667231218912
  4. "Mass Spectrometry for Neurobiomarker Discovery: The Relevance of Post-Translational Modifications". Cells 11 8 (2022): 1279-1279. http://dx.doi.org/10.3390/cells11081279.
    10.3390/cells11081279
  5. Gaiteiro, Cristiana; Soares, Janine; Relvas-Santos, Marta; Peixoto, Andreia; Ferreira, Dylan; Paulo, Paula; Brandão, Andreia; et al. "Glycoproteogenomics characterizes the CD44 splicing code associated with bladder cancer invasion". Theranostics 12 7 (2022): 3150-3177. http://dx.doi.org/10.7150/thno.67409.
    10.7150/thno.67409
  6. Peixoto A; Ferreira D; Azevedo R; Freitas R; Fernandes E; Relvas-Santos M; Gaiteiro C; et al. "Glycoproteomics identifies HOMER3 as a potentially targetable biomarker triggered by hypoxia and glucose deprivation in bladder cancer.". Journal of experimental & clinical cancer research : CR (2021): http://europepmc.org/abstract/med/34108014.
    10.1186/s13046-021-01988-6
  7. Sofia Cotton; Dylan Ferreira; Janine Soares; Andreia Peixoto; Marta Relvas-Santos; Rita Azevedo; Paulina Piairo; et al. "Target Score—A Proteomics Data Selection Tool Applied to Esophageal Cancer Identifies GLUT1-Sialyl Tn Glycoforms as Biomarkers of Cancer Aggressiveness". International Journal of Molecular Sciences 22 4 (2021): 1664-1664. https://doi.org/10.3390/ijms22041664.
    10.3390/ijms22041664
  8. Freitas, R.; Relvas-Santos, M.; Azevedo, R.; Soares, J.; Fernandes, E.; Teixeira, B.; Santos, L.L.; et al. "Single-pot enzymatic synthesis of cancer-associated MUC16: O -glycopeptide libraries and multivalent protein glycoconjugates: A step towards cancer glycovaccines". New Journal of Chemistry 45 20 (2021): 9197-9211. http://www.scopus.com/inward/record.url?eid=2-s2.0-85106745147&partnerID=MN8TOARS.
    10.1039/d0nj06021f
  9. Elisabete Fernandes; Rui Freitas; Dylan Ferreira; Janine Soares; Rita Azevedo; Cristiana Gaiteiro; Andreia Peixoto; et al. "Nucleolin-Sle A Glycoforms as E-Selectin Ligands and Potentially Targetable Biomarkers at the Cell Surface of Gastric Cancer Cells". Cancers (2020): https://doi.org/10.3390/cancers12040861.
    10.3390/cancers12040861
  10. Peixoto A; Relvas-Santos M; Azevedo R; Santos LL; Ferreira JA. "Protein Glycosylation and Tumor Microenvironment Alterations Driving Cancer Hallmarks.". Frontiers in oncology (2019): http://europepmc.org/abstract/med/31157165.
    10.3389/fonc.2019.00380
  11. Manuel Neves; Rita Azevedo; Luís Lima; Marta I. Oliveira; Andreia Peixoto; Dylan Ferreira; Janine Soares; et al. "Exploring sialyl-Tn expression in microfluidic-isolated circulating tumour cells: A novel biomarker and an analytical tool for precision oncology applications". New Biotechnology 49 (2019): 77-87. https://doi.org/10.1016/j.nbt.2018.09.004.
    10.1016/j.nbt.2018.09.004
  12. Azevedo R; Soares J; Gaiteiro C; Peixoto A; Lima L; Ferreira D; Relvas-Santos M; et al. "Glycan affinity magnetic nanoplatforms for urinary glycobiomarkers discovery in bladder cancer.". Talanta (2018): http://europepmc.org/abstract/med/29674052.
    10.1016/j.talanta.2018.03.028
  13. Azevedo R; Gaiteiro C; Peixoto A; Relvas-Santos M; Lima L; Santos LL; Ferreira JA. "CD44 glycoprotein in cancer: a molecular conundrum hampering clinical applications.". Clinical proteomics (2018): http://europepmc.org/abstract/med/29983670.
    10.1186/s12014-018-9198-9
  14. Rita Azevedo; Janine Soares; Andreia Peixoto; Sofia Cotton; Luís Lima; Lúcio Lara Santos; José Alexandre Ferreira. "Circulating tumor cells in bladder cancer: Emerging technologies and clinical implications foreseeing precision oncology". Urologic Oncology: Seminars and Original Investigations 36 5 (2018): 221-236. https://doi.org/10.1016/j.urolonc.2018.02.004.
    10.1016/j.urolonc.2018.02.004
  15. Carrascal MA; Silva M; Ferreira JA; Azevedo R; Ferreira D; Silva AMN; Ligeiro D; et al. "A functional glycoproteomics approach identifies CD13 as a novel E-selectin ligand in breast cancer.". Biochimica et biophysica acta (2018): http://europepmc.org/abstract/med/29777742.
    10.1016/j.bbagen.2018.05.013
  16. Rita Azevedo; André M.N. Silva; Celso A. Reis; Lúcio Lara Santos; José Alexandre Ferreira. "In silico approaches for unveiling novel glycobiomarkers in cancer". Journal of Proteomics 171 (2018): 95-106. https://doi.org/10.1016/j.jprot.2017.08.004.
    10.1016/j.jprot.2017.08.004
  17. Luís Lima; Manuel Neves; Marta I. Oliveira; Lorena Dieguez; Rui Freitas; Rita Azevedo; Cristiana Gaiteiro; et al. "Sialyl-Tn identifies muscle-invasive bladder cancer basal and luminal subtypes facing decreased survival, being expressed by circulating tumor cells and metastases". Urologic Oncology: Seminars and Original Investigations 35 12 (2017): 675.e1-675.e8. https://doi.org/10.1016/j.urolonc.2017.08.012.
    10.1016/j.urolonc.2017.08.012
  18. Azevedo, Rita. "Over forty years of bladder cancer glycobiology: Where do glycans stand facing precision oncology?". Oncotarget (2017):
    10.18632/oncotarget.19433
  19. Cotton S; Azevedo R; Gaiteiro C; Ferreira D; Lima L; Peixoto A; Fernandes E; et al. "Targeted O-glycoproteomics explored increased sialylation and identified MUC16 as a poor prognosis biomarker in advanced stage bladder tumours.". (2017): http://europepmc.org/abstract/med/28156048.
    10.1002/1878-0261.12035
  20. Peixoto, A.; Fernandes, E.; Gaiteiro, C.; Lima, L.; Azevedo, R.; Soares, J.; Cotton, S.; et al. "Hypoxia enhances the malignant nature of bladder cancer cells and concomitantly antagonizes protein O-glycosylation extension". Oncotarget 7 39 (2016): 63138-63157. http://www.scopus.com/inward/record.url?eid=2-s2.0-84994050563&partnerID=MN8TOARS.
    10.18632/oncotarget.11257
  21. Lima, A.; Bernardes, M.; Azevedo, R.; Seabra, V.; Medeiros, R.; Lima A; Bernardes M; et al. "Moving toward personalized medicine in rheumatoid arthritis: SNPs in methotrexate intracellular pathways are associated with methotrexate therapeutic outcome". Pharmacogenomics 17 15 (2016): 1649-1674. http://www.scopus.com/inward/record.url?eid=2-s2.0-84991251048&partnerID=MN8TOARS.
    10.2217/pgs-2016-0067
  22. Azevedo R; Ferreira JA; Peixoto A; Neves M; Sousa N; Lima A; Santos LL. "Emerging antibody-based therapeutic strategies for bladder cancer: A systematic review.". (2015): http://europepmc.org/abstract/med/26196222.
    10.1016/j.jconrel.2015.07.002
  23. Azevedo, Rita; Bernardes, Miguel; Fonseca, João; Lima, Aurea. "Smartphone application for rheumatoid arthritis self-management: cross-sectional study revealed the usefulness, willingness to use and patients’ needs". Rheumatology International 1 (2015): 1-11. http://link.springer.com/article/10.1007%2Fs00296-015-3270-9.
    Publicado • 10.1007/s00296-015-3270-9
  24. Azevedo, Rita; Sousa, Hugo; Monteiro, Joaquim; Lima, Aurea. "Future perspectives of Smartphone applications for rheumatic diseases self-management". Rheumatology International 35 3 (2015): 419-431. http://link.springer.com/article/10.1007%2Fs00296-014-3117-9.
    Publicado • 10.1007/s00296-014-3117-9
  25. Lima A; Bernardes M; Azevedo R; Medeiros R; Seabra V. "Pharmacogenomics of Methotrexate Membrane Transport Pathway: Can Clinical Response to Methotrexate in Rheumatoid Arthritis Be Predicted?". (2015): http://europepmc.org/abstract/med/26086825.
    10.3390/ijms160613760
  26. Lima A; Sousa H; Monteiro J; Azevedo R; Medeiros R; Seabra V; Lima, Aurea; et al. "Genetic polymorphisms in low-dose methotrexate transporters: current relevance as methotrexate therapeutic outcome biomarkers.". Pharmacogenomics 15 12 (2014): 1611-1635. http://europepmc.org/abstract/med/25340735.
    Publicado • 10.2217/pgs.14.116
  27. Lima A; Bernardes M; Azevedo R; Monteiro J; Sousa H; Medeiros R; Seabra V. "SLC19A1, SLC46A1 and SLCO1B1 Polymorphisms As Predictors Of Methotrexate-Related Toxicity In Portuguese Rheumatoid Arthritis Patients.". (2014): http://europepmc.org/abstract/med/25124723.
    10.1093/toxsci/kfu162
  28. Lima, Aurea; Monteiro, Joaquim; Bernardes, Miguel; Sousa, Hugo; Azevedo, Rita; Seabra, Vítor; Medeiros, Rui. "Prediction of methotrexate clinical response in Portuguese rheumatoid arthritis patients: Implication of MTHFR rs1801133 and ATIC rs4673993 polymorphisms". BioMed Research International 2014 368681 (2014): 1-14.
    Publicado • 10.1155/2014/368681
  29. Lima, Aurea; Bernardes, Miguel; Sousa, Hugo; Azevedo, Rita; Costa, Lúcia; Ventura, Francisco; Seabra, Vítor; Medeiros, Rui. "SLC19A1 80G allele as a biomarker of methotrexate-related gastrointestinal toxicity in Portuguese rheumatoid arthritis patients". Pharmacogenomics 15 6 (2014): 807-820.
    Publicado • 10.2217/pgs.13.244
  30. Lima A; Seabra V; Bernardes M; Azevedo R; Sousa H; Medeiros R. "Role of Key TYMS Polymorphisms on Methotrexate Therapeutic Outcome in Portuguese Rheumatoid Arthritis Patients.". (2014): http://europepmc.org/abstract/med/25279663.
    10.1371/journal.pone.0108165
  31. Lima, Aurea; Azevedo, Rita; Sousa, Hugo; Seabra, Vítor; Medeiros, Rui. "Current approaches for TYMS polymorphisms and their importance in molecular epidemiology and pharmacogenetics". Pharmacogenomics 14 11 (2013): 1337-1413.
    Publicado • 10.2217/pgs.13.118
Poster em conferência
  1. Freitas, Rui; Relvas-Santos, Marta; Pereira Azevedo, Ana Rita ; Soares, Janine; Fernandes, Elisabete; Beatriz Teixeira; Santos, Lúcio; Silva, André M. N.; Ferreira, José Alexandre. Autor correspondente: Ferreira, José Alexandre. "Enzymatic synthesis of cancer-associated O-glycopeptides libraries and multivalent protein glycoconjugates: translating synthetic glycoepitopes into cancer glycovaccines". Trabalho apresentado em First Summer School in Biomedical Glycoscience, 2022.
  2. Peixoto, Andreia; Fernandes, Elisabete; Gaiteiro, Cristiana; Lima, Luís; Azevedo, Rita; Soares, Janine; Cotton, Sofia; et al. "Hypoxia enhances the malignant nature of bladder cancer cells and concomitantly antagonizes protein O-glycosylation". Trabalho apresentado em 29th International Carbohydrate Symposium (ICS 2018) by Peixoto A, 2018.
Resumo em conferência
  1. Lima, Aurea; Bernardes, Miguel; Azevedo, Rita; Medeiros, Rui; Seabra, Vítor. "Rumo à Medicina Personalizada na Artrite Reumatoide: Polimorfismos no Gene ATIC como Preditores Farmacogenéticos da Resposta Clínica ao Metotrexato". Trabalho apresentado em IV Simpósio SPR - Imagiologia, Póvoa do Varzim, 2015.
    Publicado
  2. Lima, Aurea; Bernardes, Miguel; Azevedo, Rita; Medeiros, Rui; Seabra, Vítor. "Poderão os Polimorfismos no Gene MTHFR Predizer o Perfil de Resposta Clínica ao Metotrexato em Doentes com Artrite Reumatoide?". Trabalho apresentado em IV Simpósio SPR - Imagiologia, Póvoa do Varzim, 2015.
    Publicado
  3. Lima, Aurea; Bernardes, Miguel; Azevedo, Rita; Medeiros, Rui; Seabra, Vítor. "Polimorfismos no ADORA2A como Preditores da Toxicidade ao Metotrexato na Artrite Reumatoide: Um Passo em Direção à Medicina Personalizada". Trabalho apresentado em IV Simpósio SPR - Imagiologia, IV Simpósio SPR - Imagiologia, 2015.
    Publicado
  4. Lima, Aurea; Bernardes, Miguel; Sousa, Hugo; Azevedo, Rita; Medeiros, Rui; Seabra, Vítor. "Prediction of Methotrexate Therapeutic Outcome: Can an Index Risk be more important than a Haplotype approach?". Trabalho apresentado em Second ESPT Conference "Pharmacogenomics: From Cell to Clinic", Lisboa, 2014.
    Publicado
  5. Lima, Aurea; Seabra, Vítor; Bernardes, Miguel; Azevedo, Rita; Sousa, Hugo; Medeiros, Rui. "Role of key TYMS polymorphisms on Methotrexate therapeutic outcome in Rheumatoid Arthritis Portuguese patients". Trabalho apresentado em Second ESPT Conference "Pharmacogenomics: From Cell to Clinic", Lisboa, 2014.
    Publicado
  6. Lima, Aurea; Seabra, Vítor; Bernardes, Miguel; Azevedo, Rita; Sousa, Hugo; Medeiros, Rui. "TYMS polymorphisms and methotrexate therapeutic outcome in rheumatoid arthritis Portuguese patients: analysis of key polymorphisms". Trabalho apresentado em European League Against Rheumatism Congress 2014, Paris, 2014.
    Publicado
  7. Lima, Aurea; Azevedo, Rita; Sousa, Hugo; Bernardes, Miguel; Medeiros, Rui; Seabra, Vítor. "SLC19A1, SLCO1B1 and ABCG2 polymorphisms are associated with Methotrexate-related gastrointestinal toxicity in Portuguese rheumatoid arthritis patients". Trabalho apresentado em European League Against Rheumatism Congress 2014, Paris, 2014.
    Publicado
  8. Lima, Aurea; Bernardes, Miguel; Azevedo, Rita; Sousa, Hugo; Seabra, Vítor; Medeiros, Rui. "SLC22A11 T allele (rs11231809) as a predictor of Methotrexate non-response in Portuguese rheumatoid arthritis patients". Trabalho apresentado em XVII Congresso Português de Reumatologia, Algarve, 2014.
    Publicado
Atividades

Apresentação oral de trabalho

Título da apresentação Nome do evento
Anfitrião (Local do evento)
2018/06/16 CD44-glycoprofilling: Estabilishing the molecular basis for targeted therapeutics in bladder cancer 29th International Carbohydrate Symposium – ICS2018
Faculdade de Ciências da Universidade de Lisboa (Lisboa, Portugal)
2017/09/12 Targeted O-glycoproteomics explored increased sialylation and identified MUC16 as a poor prognosis biomarker in advanced stage bladder tumours 12ª Reunião do Grupo de Glúcidos – GLUPOR12
Universidade de Aveiro (Aveiro, Portugal)

Participação em evento

Descrição da atividade
Tipo de evento 		Nome do evento
Instituição / Organização
2023/06/20 - 2023/06/23 ProteoAix 2023, the 3rd Joint Meeting of Spanish, French, and Portuguese Proteomics Societies. Aix en Provence, France.
Congresso
 ProteoAix 2023
2022/08/29 - 2022/09/02 Poster communication - Integrated Mass Spectrometry-based Pipeline for Characterization of Tau in Human Alzheimer’s Brain: Development and Comparison of Sample Preparation Methods. International Mass Spectrometry Conference Annual General Meeting 2022 (IMSC22).
Congresso
 International Mass Spectrometry Conference Annual General Meeting 2022
2022/07/31 - 2022/08/04 Poster communication - Integrated Mass Spectrometry-based Pipeline for Characterization of Tau in Human Alzheimer’s Brain: Development and Comparison of Sample Preparation Methods. Alzheimer's Association International Conference 2022 (AAIC22).
Congresso
 Alzheimer's Association International Conference 2022
Alzheimer's Association, Estados Unidos
2021/11/08 - 2021/11/19 HUPO ReCONNECT 2021 Congress with pre-congress training course and bioinformatics hub. Virtual.
Congresso
 HUPO ReCONNECT 2021 Congress
Human Proteome Organisation, Canadá
2021/05/18 - 2021/05/19 31st HUPO Human Brain Proteome Project Workshop. Virtual workshop in Neuroproteomics.
Oficina (workshop)
 31st HUPO Human Brain Proteome Project Workshop
Human Proteome Organisation, Canadá
2016/04/28 - 2016/04/28 Poster communication - Emerging Antibody-Based Therapeutic Strategies For Bladder Cancer: A Systematic Review. 2nd ASPIC International Congress. (IPO-Porto Auditorium, Portugal).
Congresso
 2nd ASPIC International Congress
Associação Portuguesa de Investigação em Cancro, Portugal
2016/04/07 - 2016/04/09 Poster communication - Antibody-Based Therapeutic Strategies In Clinical Phase Trials For Bladder Cancer: A Systematic Review. Encontros da Primavera – Oncology Spring Meeting 2016 (Évora Hotel, Portugal).
Encontro
 Encontros da Primavera – Oncology Spring Meeting 2016
2014/05/22 - 2014/05/23 Guest Speaker of the theme “Geração ‘Smartphones’”. XV Scientific Conference of Pharmaceutical Sciences, Higher Institute of Health Sciences - North (ISCS-N), “Estratégias terapêuticas personalizadas”. Organization: Student association of ISCS-N. Exponor.
Encontro
 XV Scientific Conference of Pharmaceutical Sciences
Instituto Universitário de Ciências da Saúde, Portugal

Curso / Disciplina lecionado

Disciplina Curso (Tipo) Instituição / Organização
2016/03/10 - 2016/03/10 Theoretical and Practical Course of Molecular Biology Applied to Oncology 1st Precision Oncology Meeting - Porto – “From basic research to clinical practice” Universidade Fernando Pessoa, Portugal

Membro de associação

Nome da associação Tipo de participação
2023/01/01 - Atual Rede ProcuraOmics (Sociedade Portuguesa de Proteomica) Member
2022/11/01 - Atual American Chemical Society (ACS) Member
2017/09/01 - Atual Portuguese Association of Chemistry (Sociedade Portuguesa de Química) Member
2016/02/01 - Atual European Association for Cancer Research (EACR) Member
2016/02/01 - Atual Portuguese Association for Cancer Research (Associação Portuguesa de Investigação em Cancro – ASPIC) Member
2023/01/01 - 2023/12/31 Société Française de Spectrométrie de Masse (SFSM) Member
2021/01/01 - 2022/01/31 American Society for Biochemistry and Molecular Biology (ASBMB) Member

Revisão ad hoc de artigos em revista

Nome da revista (ISSN) Editora
2024 - 2024 Gene
2016 - 2016 Rheumatology International
Distinções

Prémio

2013 Best student 2011-2012 of Degree in Biochemistry at ISCS-N
Cooperativa de Ensino Superior Politécnico e Universitário, CESPU, Portugal